amgen glp-1 Amgen's Once-Monthly Drug for Obesity and Diabetes | Ahmad Bahareth, MD posted on the topic GLP-1 Agonists: A Comprehensive Overview

She is truly phenomenal and has such a deep passion for what she does which reflects in all of her work

Verified absence of harmful bacteria, heavy metals, and contaminants

Leptin ameliorates ischemic necrosis of the femoral head in rats with obesity induced by a high-fat diet

They point to effects beyond appetite suppression, from reduced inflammation to possible direct signalling on tumour cells. F&B takeaway: It almost goes without saying that GLP-1s for cancer prevention or treatment would dramatically accelerate their adoption, both in private use and in public health systems, shifting them firmly into the health space

doi:10.1056/NEJMoa2307563 Jastreboff AM, Aronne LJ, Ahmad NN, et al

Getting into the details of dosing and devices that administer the medication is important: FDA-approved doses should be increased only under the ongoing supervision of the prescribing medical professional